Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gatifloxacin vs Ceftriaxone for Uncomplicated Enteric Fever
NCT01421693Phase 4Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Sep 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gatifloxacin in enteric fever (2 arms), sponsored by Oxford University Clinical Research Unit. Primary endpoint: Rate of treatment failure at 28 days. Started Sep 2011; status: completed.
02
Drugs
gatifloxacin
03
Conditions
enteric fever
Beyond the preview
Go deeper on NCT01421693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01421693.